BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8593818)

  • 1. Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3',5'-monophosphate and protein kinase A.
    Fortunati N; Fissore F; Fazzari A; Becchis M; Comba A; Catalano MG; Berta L; Frairia R
    Endocrinology; 1996 Feb; 137(2):686-92. PubMed ID: 8593818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor-mediated action of sex steroid binding protein (SBP, SHBG): accumulation of cAMP in MCF-7 cells under SBP and estradiol treatment.
    Fissore F; Fortunati N; Comba A; Fazzari A; Gaidano G; Berta L; Frairia R
    Steroids; 1994 Nov; 59(11):661-7. PubMed ID: 7701543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCF-7 cell progesterone receptor (PGR) is additionally modulated by sex steroid binding protein (SBP) and its membrane receptor (SBP-R) through cAMP and PKA.
    Fortunati N; Comba A; Becchis M; Catalano MG; Fazzari A; Fissore F; Frairia R
    Ann N Y Acad Sci; 1996 Apr; 784():453-7. PubMed ID: 8651597
    [No Abstract]   [Full Text] [Related]  

  • 4. Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG).
    Fortunati N; Fissore F; Fazzari A; Piovano F; Catalano MG; Becchis M; Berta L; Frairia R
    J Steroid Biochem Mol Biol; 1999; 70(1-3):73-80. PubMed ID: 10529004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex steroid-binding protein and its membrane receptor in estrogen-dependent breast cancer: biological and pathophysiological impact.
    Fortunati N; Fissore F; Comba A; Becchis M; Catalano MG; Fazzari A; Berta L; Frairia R
    Horm Res; 1996; 45(3-5):202-6. PubMed ID: 8964584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
    Cho H; Aronica SM; Katzenellenbogen BS
    Endocrinology; 1994 Feb; 134(2):658-64. PubMed ID: 7507831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells.
    Fortunati N; Becchis M; Catalano MG; Comba A; Ferrera P; Raineri M; Berta L; Frairia R
    J Steroid Biochem Mol Biol; 1999; 69(1-6):473-9. PubMed ID: 10419027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
    Lowe WL; Fu R; Banko M
    Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors.
    Aronica SM; Katzenellenbogen BS
    Endocrinology; 1991 Apr; 128(4):2045-52. PubMed ID: 1706263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin.
    Nakhla AM; Rosner W
    Endocrinology; 1996 Oct; 137(10):4126-9. PubMed ID: 8828467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The control of progesterone receptor expression in MCF-7 breast cancer cells: effects of estradiol and sex hormone-binding globulin (SHBG).
    Fazzari A; Catalano MG; Comba A; Becchis M; Raineri M; Frairia R; Fortunati N
    Mol Cell Endocrinol; 2001 Feb; 172(1-2):31-6. PubMed ID: 11165037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells.
    Catalano MG; Frairia R; Boccuzzi G; Fortunati N
    Mol Cell Endocrinol; 2005 Jan; 230(1-2):31-7. PubMed ID: 15664449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the membrane sex hormone-binding globulin-receptor (SHBG-R) in MCF-7 cells: effect of locally produced SHBG.
    Fortunati N; Raineri M; Cignetti A; Hammond GL; Frairia R
    Steroids; 1998; 63(5-6):282-4. PubMed ID: 9618786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol.
    Martin JL; Coverley JA; Pattison ST; Baxter RC
    Endocrinology; 1995 Mar; 136(3):1219-26. PubMed ID: 7532580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxylated estrogens (2-OH-E2 AND 4-OH-E2) do not activate cAMP/PKA and ERK1/2 pathways activation in a breast cancer MCF-7 cell line.
    Kwiecinska P; Ptak A; Wrobel A; Gregoraszczuk EL
    Endocr Regul; 2012 Jan; 46(1):3-12. PubMed ID: 22329816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological relevance of the interaction between sex steroid binding protein and its specific receptor of MCF-7 cells: effect on the estradiol-induced cell proliferation.
    Fortunati N; Fissore F; Fazzari A; Berta L; Benedusi-Pagliano E; Frairia R
    J Steroid Biochem Mol Biol; 1993 May; 45(5):435-44. PubMed ID: 8388711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
    Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D
    J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A steroid-binding protein mediates estrogen-dependent inhibition of growth of MCF-7 breast cancer cells.
    Tanji M; Carpenter DO
    Anticancer Res; 2000; 20(4):2785-9. PubMed ID: 10953358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.